ADC Therapeutics SA

NYSE:ADCT

1.96 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -240.053-155.8-230.026-246.29-116.484-123.096-89.862
Depreciation & Amortization 3.2672.3282.632.1881.6460.740.341
Deferred Income Tax 37.104-0.708-21.4790.3271.2080.9350.048
Stock Based Compensation 13.49549.32260.4837.5851.1170.4690.98
Change In Working Capital 44.271-33.01-20.2812.362-7.8830.48113.512
Accounts Receivables 47.789-42.753-30.21800.1920.8954.822
Inventory 1.608-8.964-3.0220-2.311.5845.025
Accounts Payables 3.1730.316.7981.921-3.425-0.8585.468
Other Working Capital -8.29918.3976.16210.441-2.34-1.14-1.803
Other Non Cash Items 23.231.074-24.70325.099-1.185-0.8910.036
Operating Cash Flow -118.686-136.794-233.378-168.729-121.581-121.362-74.945
Investing Activities:
Investments In Property Plant And Equipment -3.216-2.298-6.376-2.809-2.148-2.47-3.156
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0-0.21-0.297-0.019-0.1-0.036-0.092
Investing Cash Flow -3.216-2.508-6.673-2.828-2.248-2.506-3.248
Financing Activities:
Debt Repayment 0-2.70748.61461.754-1.00200
Common Stock Issued 0.7736.130.778433.1580.0410197.239
Common Stock Repurchased 0-0.22100-0.141-0.0240
Dividends Paid 0000000
Other Financing Activities 73.875-4.32218.780.054101.614-0.0240
Financing Cash Flow 73.875-0.593267.394494.966100.512-0.024197.239
Other Information:
Effect Of Forex Changes On Cash 0.184-0.2080.0060.2350.061-0.0530.037
Net Change In Cash -47.843-140.10327.349323.644-23.256-123.945119.083
Cash At End Of Period 278.598326.441466.544439.195115.551138.807262.752